Cytokines and Myelination in the Central Nervous System
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Myelin abnormalities that reflect damage to developing and mature brains are often found in neurological diseases with evidence of inflammatory infiltration and microglial activation. Many cytokines are virtually undetectable in the uninflamed central nervous system (CNS), so that their rapid induction and sustained elevation in immune and glial cells contributes to dysregulation of the inflammatory response and neural cell homeostasis. This results in aberrant neural cell development, cytotoxicity, and loss of the primary myelin-producing cells of the CNS, the oligodendrocytes. This article provides an overview of cytokine and chemokine activity in the CNS with relevance to clinical conditions of neonatal and adult demyelinating disease, brain trauma, and mental disorders with observed white matter defects. Experimental models that mimic human disease have been developed in order to study pathogenic and therapeutic mechanisms, but have shown mixed success in clinical application. However, genetically altered animals, and models of CNS inflammation and demyelination, have offered great insight into the complexities of neuroimmune interactions that impact oligodendrocyte function. The intracellular signaling pathways of selected cytokines have also been highlighted to illustrate current knowledge of receptor-mediated events. By learning to interpret the actions of cytokines and by improving methods to target appropriate predictors of disease risk selectively, a more comprehensive understanding of altered immunoregulation will aid in the development of advanced treatment options for patients with inflammatory white matter disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Chemokines are small-molecular-weight chemotactic cytokines that attract leukocytes to sites of infection and inflammation[1,2].”
BackgroundB-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094 · cited 1×
“TNFR1 is the receptor isoform primarily responsible for hyper-responsiveness, and, while the consequences of TNFR2 signaling are less well characterized, TNFR2 has been shown to mediate signals that promote tissue repair and angiogenesis[206].”
BackgroundIL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254 · cited 1×
“In response to LPS receptor binding, TLR-4 and myeloid differentiation-2 (MD-2) form a receptor complex preceding different intracellular events[181]: an early response dependent on myeloid differentiation primary response gene 88 (MyD88) and MyD88-like adapter (Mal) leading to the activation of NFκB, and a later resp…”
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 2×
“While it had been presumed that copper deficiency was primarily responsible for the lesions, it was also noted that copper administration failed to reduce cuprizone toxicity[160], and the precise mechanism of demyelination/remyelination remained unexplained.”
BackgroundEl Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Two tumour necrosis factor receptors: structure and function
Vandenabeele, P., Declercq, W., Beyaert, R., & Fiers, W. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89088-1 · Cited by 799 · cited 1×
“TNF-α binds to two distinct, but structurally related, receptors, a 55-kDa TNFR1 and a 75-kDa TNFR2[202,203], which are differentially regulated on various cell types in normal and disease states[204], and are activated with different kinetics [205].”
BackgroundYoon, B. H., Romero, R., Park, J. S., Kim, C. J., Kim, S. H., Choi, J.-H., & Han, T. R. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.104207 · Cited by 779 · cited 1×
“, IL-1β, IL-6, IL-18, IFN-γ) in amniotic fluid, umbilical cord blood, and cerebrospinal fluid (CSF), as well as the presence of chorioamnionitis and fetal vasculitis, correlate with the development or presence of WMD and impaired neurologic development in preterm infants[51,52,53,54,55].”
BackgroundExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Although no single EAE model mimics the chronic disease courses of MS, and some differences exist between various EAE models, disease severity in EAE appears to be correlated with the recruitment of activated macrophages[138], which could also mediate axonal injury in the absence of extensive myelin loss[139].”
BackgroundAstrocytes promote myelination in response to electrical impulses
Ishibashi, T., Dakin, K. A., Stevens, B., Lee, P. R., Kozlov, S. V., Stewart, C. L., & Fields, R. D. (2006) · Neuron · doi:10.1016/j.neuron.2006.02.006 · Cited by 689
Yoon, B. H., Romero, R., Yang, S. H., Jun, J. K., Kim, I.-O., Choi, J.-H., & Syn, H. C. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70585-9 · Cited by 584
Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584 · cited 7×
“[152] In mouse models, altered CCR2 is associated with early disease progression of AD.”
BackgroundInfluentialCc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511 · cited 7×
“[152] In mouse models, altered CCR2 is associated with early disease progression of AD.”
BackgroundInfluentialInterleukin-1β Promotes Repair of the CNS
Mason, J. L., Suzuki, K., Chaplin, D. D., & Matsushima, G. K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07046.2001 · Cited by 502
Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., & Tuohy, V. K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472896 · Cited by 496
Inflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385
Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines
Balasingam, V, Tejada-Berges, T., Wright, E., Bouckova, R., & Yong, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00846.1994 · Cited by 342 · cited 1×
“[234]”
Medeiros, R., Prediger, R. D. S., Passos, G. F., Pandolfo, P., Duarte, F. S., Franco, J. L., Dafre, A. L., Di Giunta, G., Figueiredo, C. P., Takahashi, R. N., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5047-06.2007 · Cited by 292
Mayer, M., Bhakoo, K., & Noble, M. (1994) · Development · doi:10.1242/dev.120.1.143 · Cited by 287
Iglesias, A., Bauer, J., Litzenburger, T., Schubart, A., & Linington, C. (2001) · Glia · doi:10.1002/glia.1111 · Cited by 280 · cited 1×
“The mouse CNS, however, is more sensitive to T-cell mediated damage[136].”
BackgroundXia, M. Q., Bacskai, B. J., Knowles, R. B., Qin, S. X., & Hyman, B. T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00285-x · Cited by 269 · cited 1×
“, CXCR2[102].”
A role for TGF-beta in oligodendrocyte differentiation.
McKinnon, R. D., Piras, G., Ida, J. A., & Dubois-Dalcq, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.6.1397 · Cited by 248 · cited 1×
“[251]”
ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · cited 1×
“An impact of chemokines in AD may be stage dependent as CCL2 was found in mature, but not immature, senile plaques[104].”
BackgroundInterleukin-1 Regulates Proliferation and Differentiation of Oligodendrocyte Progenitor Cells
Vela, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1127 · Cited by 223 · cited 3×
“oligodendrocyte differentiation, inhibiting expression of the progenitor marker PDGFRα[8].”
BackgroundInfluentialSchmidt, J., Metselaar, J. M., Wauben, M. H. M., Toyka, K. V., Storm, G., & Gold, R. (2003) · Brain · doi:10.1093/brain/awg176 · Cited by 204
Regenold, W. T., Phatak, P., Marano, C. M., Gearhart, L., Viens, C. H., & Hisley, K. C. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.019 · Cited by 178 · cited 1×
“Significantly reduced staining of MBP has been found in a study on postmortem brain sections from individuals with schizophrenia compared to controls[107].”
BackgroundCai, Z., Pang, Y., Lin, S., & Rhodes, P. G. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02545-9 · Cited by 173 · cited 1×
“Coadministration of IL-1ra with LPS significantly attenuated LPS-induced white matter injury, supporting the potency of IL-1β to cause WMD[178].”
BackgroundMarriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., Kolbe, S., Gordon, I. R., Wang, H., Egan, G., et al. (2008) · Glia · doi:10.1002/glia.20646 · Cited by 86 · cited 1×
“[252]”
Interferon-γ Protects against Cuprizone-Induced Demyelination
Gao, X., Gillig, T. A., Ye, P., D'Ercole, A. J., Matsushima, G. K., & Popko, B. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0883 · Cited by 84 · cited 2×
“in protection against severe myelin loss[23].”
The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro
Cammer, W. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00181-1 · Cited by 65 · cited 2×
“These studies, along with those of Cammer[164], indicated that the demyelinating effect of cuprizone is”
ResultDeleterious Role of IFNγ in a Toxic Model of Central Nervous System Demyelination
Maña, P., Liñares, D., Fordham, S., Staykova, M., & Willenborg, D. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050799 · Cited by 48
Trebst, C., Heine, S., Lienenklaus, S., Lindner, M., Baumgärtner, W., Weiss, S., & Stangel, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0300-z · Cited by 38 · cited 1×
“Cuprizone-induced lesions in IFN-β null mice were found to remyelinate more rapidly, concomitant with an increased number of OPCs within the demyelinated lesion[162], suggesting that elevated IFN-β prevents OPC recruitment and proliferation during remyelination.”
BackgroundMaysami, S., Nguyen, D., Zobel, F., Heine, S., Höpfner, M., & Stangel, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.021 · Cited by 25 · cited 6×
“CXCL12, via CXCR4 activation, is crucial for CNS development, as brain abnormalities are apparent in knockout mutants[38].”
BackgroundInfluential
Cited by
Early-life programming of later-life brain and behavior: a critical role for the immune system
Bilbo, S. D. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.014.2009 · Cited by 652
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke
Shi, L., Sun, Z., Su, W., Xu, F., Xie, D., Zhang, Q., Dai, X., Iyer, K., Hitchens, T. K., Foley, L. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.022 · Cited by 422
Bilbo, S. D., Block, C. L., Bolton, J. L., Hanamsagar, R., & Tran, P. K. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.002 · Cited by 319
Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111
“In a study on dementia-free subjects high levels of IL-1β and TNF-α were associated with an increased risk of developing Alzheimer’s disease [58], while the induction of Th2-biased responses seems to improve the”
BackgroundInfluential
Metadata
- Authors
- Schmitz, T., & Chew, L.-J.
- Venue
- The Scientific World JOURNAL
- Publisher
- Wiley
- Published
- 2008
- Volume
- 8
- Pages
- 1119-1147
- ISSN
- 1537-744X (ISSN-L)
- OpenAlex
- W1983074248
- Cited by
- 138
- References
- 38
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.